Redefining Heart Failure
The Utility of Genomics
Mark P. Donahue, MD, MHS*, ,*,
Douglas A. Marchuk, PhD and
Howard A. Rockman, MD*,
* Division of Cardiovascular Medicine
Duke Clinical Research Institute
Department of Molecular Genetics and Microbiology, Durham, North Carolina

View larger version (16K):
[in a new window]
|
Figure 1 Integrating genomic evidence into the management of cardiomyopathy. Genomics can potentially assist at many points of our current care model. This figure illustrates the potential points of integration of genomic information into current standard of care. EP = electrophysiology.
|
|
|